Evaluation of a new photosensitizer, meso‐tetra‐hydroxyphenyl‐chlorin, for use in photodynamic therapy: A comparison of its photobiological properties with those of two other photosensitizers
暂无分享,去创建一个
[1] K. Berg,et al. EVALUATION OF SULFONATED ALUMINUM PHTHALOCYANINES FOR USE IN PHOTOCHEMOTHERAPY. A STUDY ON THE RELATIVE EFFICIENCIES OF PHOTOINACTIVATION , 1989, Photochemistry and photobiology.
[2] J. Moan,et al. Porphyrin-sensitized photoinactivation of human cells in vitro. , 1982, The American journal of pathology.
[3] J. Moan,et al. The main photosensitizing components of hematoporphyrin derivative. , 1982, Cancer letters.
[4] D. Kessel,et al. Transport and binding of hematoporphyrin derivative and related porphyrins by murine leukemia L1210 cells. , 1981, Cancer research.
[5] T. Dougherty,et al. Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue. , 1979, Cancer research.
[6] J Moan,et al. ACTION SPECTRA FOR HEMATOPORPHYRIN DERIVATIVE AND PHOTOFRIN II WITH RESPECT TO SENSITIZATION OF HUMAN CELLS IN VITRO TO PHOTOINACTIVATION , 1984, Photochemistry and photobiology.
[7] M. Wolbarsht,et al. Measurement of the absolute rate constants for singlet molecular oxygen (1.DELTA.g) reaction with 1,3-diphenylisobenzofuran and physical quenching by ground state molecular oxygen , 1974 .
[8] J Moan,et al. Potentiation of photodynamic therapy by mitomycin C in cultured human colon adenocarcinoma cells. , 1993, Radiation research.
[9] U Althaus,et al. Effect of drug‐light interval on photodynamic therapy with meta‐tetrahydroxyphenylchlorin in malignant mesothelioma , 1993, International journal of cancer.
[10] G. H. Gijsbers,et al. Wavelength and light-dose dependence in tumour phototherapy with haematoporphyrin derivative. , 1985, British Journal of Cancer.
[11] D. Wöhrle,et al. Liposome-delivered Zn(II)-2,3-naphthalocyanines as potential sensitizers for PDT: synthesis, photochemical, pharmacokinetic and phototherapeutic studies. , 1993, Journal of photochemistry and photobiology. B, Biology.
[12] Q. Peng,et al. PHOTOSENSITIZING EFFICIENCIES, TUMOR‐ and CELLULAR UPTAKE OF DIFFERENT PHOTOSENSITIZING DRUGS RELEVANT FOR PHOTODYNAMIC THERAPY OF CANCER , 1987, Photochemistry and photobiology.
[13] M. C. Berenbaum,et al. Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results. , 1991, British journal of cancer.
[14] M C Berenbaum,et al. Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers. , 1989, The Biochemical journal.
[15] Christiaan Sybesma,et al. An introduction to biophysics , 1977 .
[16] H. Bergh,et al. Preliminary clinical results on a second generation photosensitizer: mTHPC , 1992 .
[17] R. Margalit,et al. Fluorimetric studies on the dimerization equilibrium of protoporphyrin IX and its haemato derivative. , 1983, The Biochemical journal.
[18] J Moan,et al. Evaluation of sulfonated aluminum phthalocyanines for use in photochemotherapy. Cellular uptake studies. , 1989, Cancer letters.